Linical Co., Ltd. (2183.T)

394,00 +6,00 (+1,55%) A partir del 11:14AM JST. Mercado abierto.

Linical Co., Ltd.

Shin-Osaka Brick Building
10th Floor 6-1 Miyahara 1-chome Yodogawa-ku
Osaka 532-0003
Japan
81 6 6150 2478
https://www.linical.co.jp

Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 

Ejecutivos clave

Nombre	Título	Paga	Ejecutado	Año de nacimiento
Mr. Kazuhiro Hatano	President, CEO, GM of Corporate and Sales Planning Office & Representative Director	N/A	N/A	1965
Mr. Akihiro Takahashi	Senior MD, CFO, GM of Administration Headquarters	N/A	N/A	1967
Ms. Shiori Yamaguchi	Chief Compliance Officer, Chief of Audit Office & Executive Director	N/A	N/A	1975
Mr. Keigo Tsujimoto	Executive VP & Executive Director	N/A	N/A	1964
Mr. Jun Kawai	Executive VP & Director	N/A	N/A	1968
Mr. Masaya Miyazaki	MD of Head of Asia & Director	N/A	N/A	1971
Mr. Isao Sakamoto	Executive Director	N/A	N/A	1976
Mr. Jihoon Hwang	President & CEO of Linical Korea	N/A	N/A	N/A

Los importes son a partir de y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en JPY.

Descripción

Linical Co., Ltd. provides drug development services primarily in the areas of oncology and central nervous system to pharmaceutical companies worldwide. The company offers drug development consulting services, such as market analysis of products in development, regulatory affairs consultation support, and licensing support. It also provides clinical research and development, and contract medical affairs services, including front-end services comprising project management, monitoring, quality control, vendor management, auditing, and clinical research secretariats; and back-end services, which include data management, bio statistical analysis, medical writing, pharmacovigilance, and medical management. The company was incorporated in 2005 and is headquartered in Osaka, Japan.

Gobierno corporativo

El ISS Governance QualityScore de Linical Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.